Tuesday, May 5, 2026

THE CEO CRIES FOUL: NVIDIA’s Jensen Huang Says US Is SO BLIND To China’s ‘Free Electricity’ AI Advantage

Jensen Huang warns that China may surpass the U.S. in AI due to lower energy costs and better regulations, urging optimism in the West.

Kim let Citizens Run to Celebrate ’80th Workers’ Party Anniversary’ but Who Needs Exercise Actually?

North Korea's Workers' Party celebrates its 80th anniversary with a wave of loyalty letters and national pride, highlighted by major achievements.

The New Kim Is Coming: Ju-ae Dares To Stare Down Officials—The Shocking Moment She Took Command

Kim Jong Un's daughter Ju-ae is gaining prominence as a potential successor, showcasing maturity and authority at public events.

Tag: investment

Lunit’s 200 Billion KRW Funding: How Atinum Investment Boosts AI in Healthcare

Lunit secures 30 billion KRW investment from Atinum to enhance global R&D and operations, reinforcing its position in medical AI.

$75M Bet on Next-Gen Chips: Hanmi Unveils Hybrid Bonder for HBM

Hanmi Semiconductor will launch a 2nd Gen Hybrid Bonder for HBM production and invest $75M in a new factory to meet rising demand.

LG’s AI Revolution: How Collaboration with Palantir and SkilledAI Will Transform the Future of Robotics

LG Group's chairman met with AI leaders in Silicon Valley to explore collaboration and enhance AI commercialization in manufacturing.

Lunit’s AI Innovations: How a Meeting with France’s SGPI Could Transform Healthcare

Lunit discusses collaboration with France's SGPI to enhance medical AI technology in public healthcare, aligning with a strategic partnership.

Top 3 Innovative Korean Biotech Firms Shine at Novo Nordisk Partnering Day 2026

Novo Nordisk Korea hosted Partnering Day 2026 to foster global partnerships in healthcare, highlighting innovative local biotech firms.

JW Pharmaceutical Secures Phase 1 Approval for Novel Hair Loss Treatment JW0061—What to Expect?

JW Pharmaceutical is investing in innovative hair loss treatments and expanding its drug portfolio, including successful cholesterol medications.

Samsung Biologics Wins “Sustainability Leadership” at CDMO Awards: What This Means for the Future of Biopharma

Samsung Biologics wins the Sustainability Leadership award, marking a 13-year streak and highlighting its commitment to sustainable practices.

How Will Korea’s New R&D-Linked Drug Pricing Impact the Pharma Industry in 2026?

The new drug pricing reform aims to boost R&D in the pharmaceutical industry, but raises concerns for smaller firms facing cash flow issues.

Economic Viability Confirmed: New Public Hospitals in Gyeonggi Province Set for Launch

Gyeonggi Province plans to establish two new public hospitals, showing positive economic feasibility with advanced healthcare integration.

How Wonju’s 150 Billion KRW AI Aesthetic Medical Device Project Will Transform the Beauty Sector by 2030

Wonju City plans to invest 20 billion KRW to enhance its beauty and medical device industries, focusing on AI integration by 2030.

Hyundai’s New RH Project: What Does the 9 Trillion KRW Investment in Robotics and Hydrogen Mean for the Future?

Hyundai Motor Group establishes a new division for robotics and hydrogen, aiming to streamline operations and boost investments in emerging technologies.

Celltrion’s 1 Trillion KRW Investment: A Game Changer for Biopharmaceutical Production by 2030

Celltrion plans a major expansion with over 1 trillion KRW investment, boosting production capacity for biosimilars and new drugs by 2030.

NovaCell Technology Passes KOSDAQ Evaluation: What This Means for DongKoo BioPharm’s Future

Donggu Bio Pharmaceutical announces that its invested company, Novacell Technologies, has passed the technical evaluation for KOSDAQ listing.

China Set to Overtake South Korea in OLED Production by 2029

China's OLED production is set to surpass South Korea's by 2029, driven by aggressive investments and growth in display technology.

Top News

- Our Sponsors Ad -

Follow us